Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko purchased 64,039 shares of the stock in a transaction dated Wednesday, September 12th. The shares were purchased at an average price of $1.44 per share, with a total value of $92,216.16. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of OTCMKTS REPR traded up $0.03 during midday trading on Wednesday, reaching $1.44. 19,007 shares of the stock were exchanged, compared to its average volume of 19,030. Repro-Med Systems, Inc. has a 52-week low of $0.46 and a 52-week high of $1.50.
Repro-Med Systems (OTCMKTS:REPR) last issued its quarterly earnings results on Monday, August 6th. The company reported $0.01 EPS for the quarter. The firm had revenue of $4.50 million for the quarter.
Repro-Med Systems Company Profile
Repro Med Systems, Inc designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system.
Further Reading: What are the Different Types of Leveraged Buyouts?
Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with MarketBeat.com's FREE daily email newsletter.